0.424

-0.020 (-4.50%)
Range 0.421 - 0.449   (6.65%)
Open 0.441
Previous Close 0.444
Buy Price 0.424
Buy Volume 8
Sell Price 0.426
Sell Volume 14
Volume 3,626,573
Value -
Remark
Measurement Type Value
EPS (USD) -0.472
Trailing EPS (USD) -0.444
NAV (USD) 0.232
Cash In Hand (USD) 0.132
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 1.917
Price / Cash In Hand 3.354
Issued & Paid-up Shares 79,685,700
Treasury Shares -
Market Cap (M) 35.388
Par Value (USD) n.a.
Beta - 75 Days -0.105
R-Squared - 75 Days(%) 0.02
Beta - 500 Days 0.433
R-Squared - 500 Days(%) 0.56
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 23 Oct 2020 02:12.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 11 Nov 2020
View All Events

About ZOSANO PHARMA CORP

Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a variety of indications. Its microneedle patch system has the potential to deliver numerous medications for a variety of indications in commercial markets. Its short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an existing drug and attached to an adhesive patch. Its lead product candidates, and the indications it treats include, Weekly ZP-PTH, for severe osteoporosis, ZP-Glucagon, for severe hypoglycemia, and ZP-Triptan, for migraine. In January 2014, it entered into a strategic partnership and license agreement with Novo Nordisk A/S (Novo Nordisk), to develop a microneedle patch product.

Loading Chart...